Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA)

1994 ◽  
Vol 36 (1) ◽  
pp. 27-30 ◽  
Author(s):  
P. Brugiores ◽  
A. Gaston ◽  
H. R. Degryse ◽  
P. M. Parizel ◽  
A. M. de Schepper ◽  
...  
Keyword(s):  
Double Blind Trial ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Blind Trial ◽  
Gadolinium Complexes

scholarly journals Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial

2021 ◽  
Vol 20 (1) ◽  
pp. 38-48 ◽  
Author(s):  
Bardia Nourbakhsh ◽  
Nisha Revirajan ◽  
Bridget Morris ◽  
Christian Cordano ◽  
Jennifer Creasman ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Double Blind Trial ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Blind Trial

scholarly journals Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia

2015 ◽  
Vol 25 (5) ◽  
pp. 384-396 ◽  
Author(s):  
Robert L. Findling ◽  
Ronald P. Landbloom ◽  
Mary Mackle ◽  
Wendi Pallozzi ◽  
Sabine Braat ◽  
...  
Keyword(s):  
Double Blind Trial ◽  
Open Label ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Blind Trial ◽  
Open Label Extension

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial

2009 ◽  
Vol 8 (1) ◽  
pp. 39-47 ◽  
Author(s):  
Alistair Burns ◽  
Roberto Bernabei ◽  
Roger Bullock ◽  
Alfonso J Cruz Jentoft ◽  
Lutz Frölich ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Double Blind Trial ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Blind Trial

scholarly journals A randomised, double-blind, trial of the safety and efficacy of omarigliptin (a once-weekly DPP-4 inhibitor) in subjects with type 2 diabetes and renal impairment

2017 ◽  
Vol 71 (6) ◽  
pp. e12955 ◽  
Author(s):  
Antonio Chacra ◽  
Ira Gantz ◽  
Geraldine Mendizabal ◽  
Lucila Durlach ◽  
Edward A. O'Neill ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Renal Impairment ◽  
Double Blind Trial ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Blind Trial
Sign in / Sign up

Export Citation Format

Share Document